Cytochrome P450 3A4 suppression by epimedium and active compound kaempferol leads to synergistic anti-inflammatory effect with corticosteroid.
Li K, Yu XH, Maskey AR, Musa I, Wang ZZ, Garcia V, Guo A, Yang N, Srivastava K, Dunkin D, Li JX, Guo L, Cheng YC, Yuan H, Tiwari R, Li XM.
Li K, et al. Among authors: yang n.
Front Pharmacol. 2023 Jan 30;13:1042756. doi: 10.3389/fphar.2022.1042756. eCollection 2022.
Front Pharmacol. 2023.
PMID: 36793921
Free PMC article.